Nature’s Sunshine (NATR) Products announced the launch of an underwritten secondary public offering of up to 2.85M shares of its common stock to be sold by Fosun Pharma USA. The selling stockholder will receive all of the net proceeds from the offering. D.A. Davidson & Co. is acting as sole book-running manager and representative of the underwriters for the offering.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NATR:
- Nature’s Sunshine files to sell 2.85M shares of common stock for holders
- Nature’s Sunshine Products: Strategic Leadership Transition and Strong Financial Outlook Support Buy Rating
- Nature’s Sunshine CEO Terrence Moorehead Steps Down
- Nature’s Sunshine CEO Terrence Moorehead to step down
- Nature’s Sunshine Products Shines in 2025 Earnings Call